Where does Chris Gibson work?

Chris Gibson is Co-founder, Chairman of the Board of Recursion (NASDAQ: RXRX) and Operating Partner at Dimension Capital and Co-founder and CTO at Kaleidoscope Bio.

What check size does Chris Gibson write?

Chris Gibson typically writes checks of $5K – $50K.

What companies did Chris Gibson found?

Chris Gibson founded Recursion (NASDAQ: RXRX), Kaleidoscope Bio.

Where did Chris Gibson go to school?

Chris Gibson studied at University of Utah (Ph.D., Bioengineering); Stanford University Graduate School of Business (IGNITE Certificate, Entrepreneurship/Entrepreneurial Studies); Rice University (Bachelor of Science (B.S.), Bioengineering and Biomedical Engineering).

Chris Gibson

InvestorUnicorn founder

Co-founder, Chairman of the Board at Recursion (NASDAQ: RXRX) · Operating Partner at Dimension Capital · Portfolio Director, Private Equity at Bridges Fund Management Ltd. · Co-founder and CTO at Kaleidoscope Bio

Salt Lake City, Utah

Writes $5K – $50K checks · typically $25K

FoundedRecursion (NASDAQ: RXRX)$2.9B Kaleidoscope Bio

Find your path to Chris

343 people in our graph share verified history with Chris — schools, employers, funds. One of them is your warm intro.

Elliot GeidtunlockedChris: together at Stanford University Graduate School of Business (2013)

×8Chris: together at Stanford University Graduate School of Business

Chris: together at Divergence Labs

Chris: together at Bridges Fund Management Ltd.

About

Chris Gibson is a Portfolio Director in Bridges' Private Equity team, working with purpose-driven management teams to scale early-growth-stage businesses. Before Bridges he spent nine years as a Director at the Flowerdale Group overseeing its private equity portfolio in Hong Kong and London, and served as CFO of a US paper-crafting brand he helped relaunch, scale and exit. He qualified as a Chartered Accountant with KPMG in South Africa after studying Finance & Accounting at the University of Cape Town.

Contact· self-published, not guessed

c•••@bridgesfundmanagement.comreveal

Likely emails· guessed from name + firm domain, not firm-published

c•••@recursion.comreveal90% confident
c•••@recursion.comreveal75% confident

Invests in

Advanced ManufacturingConsumerE-commerceImpact & Social Good

Co-founder, Chairman of the Board at Recursion (NASDAQ: RXRX)

Intro paths

→

In turn, Chris can intro founders to Recursion (NASDAQ: RXRX)'s investors below.

Recursion (NASDAQ: RXRX)'s investors · 22

Air Street CapitalSt. Peter Port · $500K – $10M checks Amplify PartnersMenlo Park · $500K – $5M checks Baillie GiffordEdinburgh Catalio Capital Management, LPNew York Central Texas Angel NetworkAustin CRV (Charles River Ventures)Bay Area · $250K – $5M checks · since 2017 DCVC (Data Collective)Palo Alto · $5M – $25M checks · since 2020 EPIC VENTURESSalt Lake City Felicis VenturesSan Francisco · $500K – $15M checks KinnevikStockholm Lux CapitalNew York · $100K – $100M checks · since 2017 Lux VenturesNew York Manta Ray VenturesLondon Menlo VenturesSan Francisco · $1M – $20M checks · since 2017 National Institutes of Health (NIH)since 2015 Necessary VenturesSan Francisco · $1M – $2M checks Novo HoldingsCopenhagen · $1.1M – $54M checks NVIDIASanta Clara Obvious VenturesSan Francisco · $250K – $6M checks · since 2017 SoftBank Vision FundLondon Transform Capital ManagementSan Francisco Village GlobalCovina · $100K – $500K checks

Co-founders at Recursion (NASDAQ: RXRX)

Blake C. BorgesonExecutive Officer, Director

Co-founder and CTO at Kaleidoscope Bio

Intro paths

→

In turn, Chris can intro founders to Kaleidoscope Bio's investors below.

Kaleidoscope Bio's investors · 7

3x5 PartnersPortland · since 2022 AIN VenturesNew York · $500K – $1M checks Burda Principal InvestmentsMunich Dimension CapitalSan Francisco · $1M – $10M checks HAWKTAILSan Francisco Hummingbird VenturesSingapore · $500K – $10M checks Rally Ventures Management, LlcMenlo Park · $100K – $4M checks · since 2022

Co-founders at Kaleidoscope Bio

Ewan TaylorCSO and Co-founder

Geraldine PaulusCo-founder, VP Operations

David YenFounder

Bogdan KnezevicFounder

Experience

BOXBOXCo-Founder and CEOcurrent2026 — presentNew York, United States
DIMENSIONOperating Partnercurrent2026 — presentSan Francisco Bay Area and New York
PacBioMember Board of Directorscurrent2026 — present
Divergence LabsBoard Membercurrent2026 — present
CellinoBoard Membercurrent2024 — present
The Salt Lake TribuneBoard Membercurrent2024 — present
Project GammaCo-Founder and Managing Directorcurrent2024 — present
RecursionCo-Founder and Chairman2026
RecursionCo-Founder and CEO2013 — 2026Salt Lake City Metropolitan Area
Cure HHTMember Board of Directors2016 — 2020
University of UtahMD/PhD Student2009 — 2013
UTHSCSAMD/PhD Student2005 — 2009

Skills & more

Entrepreneurship14Molecular Biology29Drug Discovery34Cell Culture19Microscopy13Confocal Microscopy11Bioinformatics11Tissue Culture8Medicine7Genetics7Cell Biology12Cell5

+12 more

Assay DevelopmentBiomedical EngineeringLife SciencesBiotechnologyTissue EngineeringBiomaterialsBioengineeringImmunofluorescenceBiomedical DevicesStem CellsCardiovascular BiologyHigh-Throughput Screening

Languages French

From Chris's professional profile.

Colleagues at Dimension Capital

Adam Goulburn

Founder and Managing Partner at Dimension Capital

Alana Green

Investor at Dimension Capital

Amy Zhen

Investor at Dimension Capital

Anna Bitton

CFO at Torch Capital

AnneMarie Bott

Investor at Dimension Capital

Bauer LeSavage

Research Associate at Dimension Capital

Frank Gao

Investor at Dimension Capital

Nan Li

Founder and Managing Partner at Dimension Capital

Network11

Adam GoulburnScout

Founder and Managing Partner at Dimension Capital

Andrew BeebeScout

Managing Director at Obvious Ventures

Ann DeWittScout

General Partner at The Engine Ventures

Dylan ReidScout

Investor at Zetta Venture Partners

Eli CasdinScout

Chief Investment Officer and Founder at Casdin Capital

Francois ColletScout

General Partner at Isai

Fred MollScout

Co-Founder and Partner at Sonder Capital

James HardimanScout

General Partner at DCVC (Data Collective)

Michael SidlerScout

Founding Partner at redalpine

Alex Morgan

Investor at Khosla Ventures

Celine Passedouet

Investment Director at Elaia

Investors connected to Chris in public investor directories — a warm-intro map.

Frequently asked questions

Who is Chris Gibson?: Chris Gibson is a Portfolio Director in Bridges' Private Equity team, working with purpose-driven management teams to scale early-growth-stage businesses. Before Bridges he spent nine years as a Director at the Flowerdale Group overseeing its private equity portfolio in Hong Kong and London, and served as CFO of a US paper-crafting brand he helped relaunch, scale and exit. He qualified as a Chartered Accountant with KPMG in South Africa after studying Finance & Accounting at the University of Cape Town.
Where does Chris Gibson work?: Chris Gibson is Co-founder, Chairman of the Board of Recursion (NASDAQ: RXRX) and Operating Partner at Dimension Capital and Co-founder and CTO at Kaleidoscope Bio.
What does Chris Gibson invest in?: Chris Gibson invests in Advanced Manufacturing, Consumer, E-commerce, Impact & Social Good.
What check size does Chris Gibson write?: Chris Gibson typically writes checks of $5K – $50K.
What companies did Chris Gibson found?: Chris Gibson founded Recursion (NASDAQ: RXRX), Kaleidoscope Bio.
Where did Chris Gibson go to school?: Chris Gibson studied at University of Utah (Ph.D., Bioengineering); Stanford University Graduate School of Business (IGNITE Certificate, Entrepreneurship/Entrepreneurial Studies); Rice University (Bachelor of Science (B.S.), Bioengineering and Biomedical Engineering).